P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA by SEGBEFIA C., DEI-ADOMAKOH Y., MENSAH E., THOTA P., ODAME I.

Get full text

P-003: EVALUATION OF TREATMENT PATTERN, HEALTHCARE RESOURCE UTILIZATION AND COSTS OF ILLNESS FOR SICKLE CELL DISEASE IN GHANA: A PRIVATE MEDICAL INSURANCE CLAIMS DATABASE STUDY by DEI-ADOMAKOH Y., SEGBEFIA C., DWOMOH D., MARFO K., EDGAL A., EGBUJO O., ATAGA K.

Get full text

P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE by SMART L., SEGBEFIA C., LATHAM T., STUBER S., AMISSAH-ARTHUR K., LANE A., DEI-ADOMAKOH Y., WARE R.

Get full text

P-002: MULTISPECTRAL IMAGING FOR MICROCHIP ELECTROPHORESIS ENABLES POINT-OF-CARE NEWBORN HEMOGLOBIN VARIANT SCREENING by AN R., HUANG Y., ROCHELEAU A., AVANAKI A., THOTA P., ZHANG Q., MAN Y., SEKYONDA Z., SEGBEFIA C., DEI-ADOMAKOH Y., MENSAH E., OHENE-FREMPONG K., ODAME I., OWUSU-ANSAH A., GURKAN U.

Get full text